Creatine kinase and platelets

Completed

• Conditions: bleeding; 10064477

• Registration Number: NL-OMON43085
• Lead Sponsor: Academisch Medisch Centrum

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Last Update Posted: 23 April 2024

Recruitment & Eligibility

• Status: Completed
• Sex: Not specified
• Target Recruitment: 6

Inclusion Criteria

Healthy volunteers 18-60 years old not using any medication

Exclusion Criteria

A potential subject who meets any of the following criteria will be excluded from participation in this study: any known disease as assessed by history taking or the obligatory use of (prescription) drugs.

Study & Design

• Study Type: Observational invasive
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
<p>Inhibition of the effect of creatine kinase on platelets in vitro</p><br>

Secondary Outcome Measures

Name	Time	Method
<p>not applicable</p><br>